Age and gender-specific reference intervals for uric acid level and hyperuricemia in children with Down syndrome

Toshiyuki Kitoh1,2, Tatsuro Yamana1, Hirofumi Imura1

  • 1Laboratory of Pediatrics, Aichi Gakuin University, School of Pharmacy, Nagoya, Japan.

Insights

Children with Down syndrome (DS) have higher uric acid (UA) levels and a greater prevalence of hyperuricemia. New reference values are crucial for monitoring and treating UA in this population.

Area of Science:

  • Pediatrics
  • Genetics
  • Clinical Biochemistry

Background:

  • The association between Down syndrome (DS) and hyperuricemia is long-established.
  • Defining age- and gender-specific uric acid (UA) reference values for children with DS is essential for accurate hyperuricemia diagnosis.

Purpose of the Study:

  • To establish age- and gender-specific reference uric acid (UA) values for children with Down syndrome (DS).
  • To determine the prevalence of hyperuricemia in children with DS and identify associated factors.

Main Methods:

  • Analysis of laboratory data from 238 children (140 males, 98 females) with DS under 21 years of age.
  • Exclusion of 14 patients already diagnosed and treated for hyperuricemia.
  • Calculation of reference UA levels based on age and gender, and investigation of correlations with other clinical and laboratory findings.

Main Results:

  • Children with DS exhibited significantly higher UA levels compared to the general population across all age groups.
  • Newly established reference values identified 55 patients with hyperuricemia, with prevalence rates of 25.0% in males and 20.4% in females.
  • UA levels correlated with hemoglobin, creatinine, and total bilirubin, suggesting a link with dehydration in children with DS. Hyperuricemia cases increased notably after age 10.

Conclusions:

  • The established reference UA levels provide a basis for evaluating hyperuricemia in children with DS.
  • These findings highlight the need for careful monitoring and potential treatment with uric-acid-lowering drugs for children with DS and hyperuricemia.
Abstract

Related Concept Videos

Factors Affecting Renal Clearance: Renal Impairment01:17

Factors Affecting Renal Clearance: Renal Impairment

Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
46
Karyotyping01:17

Karyotyping

Overview
56.0K
Sex-linked Disorders01:43

Sex-linked Disorders

Like autosomes, sex chromosomes contain a variety of genes necessary for normal body function. When a mutation in one of these genes results in biological deficits, the disorder is considered sex-linked.
99.5K
Meiosis vs. Mitosis02:57

Meiosis vs. Mitosis

Cell division is necessary for growth and reproduction in organisms. Mitosis aids cell growth and development by dividing somatic cells. In contrast, meiosis causes the division of germ cells and plays an essential role in sexual reproduction. Due to their unique functional requirements, mitosis and meiosis differ from each other in multiple aspects.
Before the start of mitosis and meiosis I, the cell synthesizes DNA, resulting in two homologous copies of each chromosome. DNA synthesis is...
51.9K
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
121